Global Molecular Oncology Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Molecular Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 PCR
  • 1.2.3 NGS (Next Generation Sequencing)
  • 1.2.4 Microarray
  • 1.2.5 FISH (Fluorescent in situ-hybridization)
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Molecular Oncology Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Diagnostic Laboratories
  • 1.3.4 Cancer Centers and Specialty Clinics
  • 1.3.5 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Molecular Oncology Market Perspective (2019-2030)
• 2.2 Global Molecular Oncology Growth Trends by Region
  • 2.2.1 Global Molecular Oncology Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Molecular Oncology Historic Market Size by Region (2019-2024)
  • 2.2.3 Molecular Oncology Forecasted Market Size by Region (2025-2030)
• 2.3 Molecular Oncology Market Dynamics
  • 2.3.1 Molecular Oncology Industry Trends
  • 2.3.2 Molecular Oncology Market Drivers
  • 2.3.3 Molecular Oncology Market Challenges
  • 2.3.4 Molecular Oncology Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Molecular Oncology by Players
  • 3.1.1 Global Molecular Oncology Revenue by Players (2019-2024)
  • 3.1.2 Global Molecular Oncology Revenue Market Share by Players (2019-2024)
• 3.2 Global Molecular Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Molecular Oncology, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Molecular Oncology Market Concentration Ratio
  • 3.4.1 Global Molecular Oncology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Molecular Oncology Revenue in 2023
• 3.5 Global Key Players of Molecular Oncology Head office and Area Served
• 3.6 Global Key Players of Molecular Oncology, Product and Application
• 3.7 Global Key Players of Molecular Oncology, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Oncology Breakdown Data by Type

• 4.1 Global Molecular Oncology Historic Market Size by Type (2019-2024)
• 4.2 Global Molecular Oncology Forecasted Market Size by Type (2025-2030)

5 Molecular Oncology Breakdown Data by Application

• 5.1 Global Molecular Oncology Historic Market Size by Application (2019-2024)
• 5.2 Global Molecular Oncology Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Molecular Oncology Market Size (2019-2030)
• 6.2 North America Molecular Oncology Market Size by Type
  • 6.2.1 North America Molecular Oncology Market Size by Type (2019-2024)
  • 6.2.2 North America Molecular Oncology Market Size by Type (2025-2030)
  • 6.2.3 North America Molecular Oncology Market Share by Type (2019-2030)
• 6.3 North America Molecular Oncology Market Size by Application
  • 6.3.1 North America Molecular Oncology Market Size by Application (2019-2024)
  • 6.3.2 North America Molecular Oncology Market Size by Application (2025-2030)
  • 6.3.3 North America Molecular Oncology Market Share by Application (2019-2030)
• 6.4 North America Molecular Oncology Market Size by Country
  • 6.4.1 North America Molecular Oncology Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Molecular Oncology Market Size by Country (2019-2024)
  • 6.4.3 North America Molecular Oncology Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Molecular Oncology Market Size (2019-2030)
• 7.2 Europe Molecular Oncology Market Size by Type
  • 7.2.1 Europe Molecular Oncology Market Size by Type (2019-2024)
  • 7.2.2 Europe Molecular Oncology Market Size by Type (2025-2030)
  • 7.2.3 Europe Molecular Oncology Market Share by Type (2019-2030)
• 7.3 Europe Molecular Oncology Market Size by Application
  • 7.3.1 Europe Molecular Oncology Market Size by Application (2019-2024)
  • 7.3.2 Europe Molecular Oncology Market Size by Application (2025-2030)
  • 7.3.3 Europe Molecular Oncology Market Share by Application (2019-2030)
• 7.4 Europe Molecular Oncology Market Size by Country
  • 7.4.1 Europe Molecular Oncology Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Molecular Oncology Market Size by Country (2019-2024)
  • 7.4.3 Europe Molecular Oncology Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Molecular Oncology Market Size (2019-2030)
• 8.2 China Molecular Oncology Market Size by Type
  • 8.2.1 China Molecular Oncology Market Size by Type (2019-2024)
  • 8.2.2 China Molecular Oncology Market Size by Type (2025-2030)
  • 8.2.3 China Molecular Oncology Market Share by Type (2019-2030)
• 8.3 China Molecular Oncology Market Size by Application
  • 8.3.1 China Molecular Oncology Market Size by Application (2019-2024)
  • 8.3.2 China Molecular Oncology Market Size by Application (2025-2030)
  • 8.3.3 China Molecular Oncology Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Molecular Oncology Market Size (2019-2030)
• 9.2 Asia Molecular Oncology Market Size by Type
  • 9.2.1 Asia Molecular Oncology Market Size by Type (2019-2024)
  • 9.2.2 Asia Molecular Oncology Market Size by Type (2025-2030)
  • 9.2.3 Asia Molecular Oncology Market Share by Type (2019-2030)
• 9.3 Asia Molecular Oncology Market Size by Application
  • 9.3.1 Asia Molecular Oncology Market Size by Application (2019-2024)
  • 9.3.2 Asia Molecular Oncology Market Size by Application (2025-2030)
  • 9.3.3 Asia Molecular Oncology Market Share by Application (2019-2030)
• 9.4 Asia Molecular Oncology Market Size by Region
  • 9.4.1 Asia Molecular Oncology Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Molecular Oncology Market Size by Region (2019-2024)
  • 9.4.3 Asia Molecular Oncology Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Molecular Oncology Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Molecular Oncology Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Molecular Oncology Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Molecular Oncology Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Molecular Oncology Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Molecular Oncology Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Molecular Oncology Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Molecular Oncology Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Molecular Oncology Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Molecular Oncology Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Molecular Oncology Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Molecular Oncology Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Molecular Oncology Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Roche Diagnostics
  • 11.1.1 Roche Diagnostics Company Details
  • 11.1.2 Roche Diagnostics Business Overview
  • 11.1.3 Roche Diagnostics Molecular Oncology Introduction
  • 11.1.4 Roche Diagnostics Revenue in Molecular Oncology Business (2019-2024)
  • 11.1.5 Roche Diagnostics Recent Development
• 11.2 Thermo Fisher Scientific Inc.
  • 11.2.1 Thermo Fisher Scientific Inc. Company Details
  • 11.2.2 Thermo Fisher Scientific Inc. Business Overview
  • 11.2.3 Thermo Fisher Scientific Inc. Molecular Oncology Introduction
  • 11.2.4 Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.2.5 Thermo Fisher Scientific Inc. Recent Development
• 11.3 Illumina, Inc.
  • 11.3.1 Illumina, Inc. Company Details
  • 11.3.2 Illumina, Inc. Business Overview
  • 11.3.3 Illumina, Inc. Molecular Oncology Introduction
  • 11.3.4 Illumina, Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.3.5 Illumina, Inc. Recent Development
• 11.4 Qiagen N.V.
  • 11.4.1 Qiagen N.V. Company Details
  • 11.4.2 Qiagen N.V. Business Overview
  • 11.4.3 Qiagen N.V. Molecular Oncology Introduction
  • 11.4.4 Qiagen N.V. Revenue in Molecular Oncology Business (2019-2024)
  • 11.4.5 Qiagen N.V. Recent Development
• 11.5 Agilent Technologies, Inc.
  • 11.5.1 Agilent Technologies, Inc. Company Details
  • 11.5.2 Agilent Technologies, Inc. Business Overview
  • 11.5.3 Agilent Technologies, Inc. Molecular Oncology Introduction
  • 11.5.4 Agilent Technologies, Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.5.5 Agilent Technologies, Inc. Recent Development
• 11.6 Abbott Laboratories
  • 11.6.1 Abbott Laboratories Company Details
  • 11.6.2 Abbott Laboratories Business Overview
  • 11.6.3 Abbott Laboratories Molecular Oncology Introduction
  • 11.6.4 Abbott Laboratories Revenue in Molecular Oncology Business (2019-2024)
  • 11.6.5 Abbott Laboratories Recent Development
• 11.7 Bio-Rad Laboratories, Inc.
  • 11.7.1 Bio-Rad Laboratories, Inc. Company Details
  • 11.7.2 Bio-Rad Laboratories, Inc. Business Overview
  • 11.7.3 Bio-Rad Laboratories, Inc. Molecular Oncology Introduction
  • 11.7.4 Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.7.5 Bio-Rad Laboratories, Inc. Recent Development
• 11.8 Myriad Genetics, Inc.
  • 11.8.1 Myriad Genetics, Inc. Company Details
  • 11.8.2 Myriad Genetics, Inc. Business Overview
  • 11.8.3 Myriad Genetics, Inc. Molecular Oncology Introduction
  • 11.8.4 Myriad Genetics, Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.8.5 Myriad Genetics, Inc. Recent Development
• 11.9 Genomic Health, Inc.
  • 11.9.1 Genomic Health, Inc. Company Details
  • 11.9.2 Genomic Health, Inc. Business Overview
  • 11.9.3 Genomic Health, Inc. Molecular Oncology Introduction
  • 11.9.4 Genomic Health, Inc. Revenue in Molecular Oncology Business (2019-2024)
  • 11.9.5 Genomic Health, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Molecular Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of NGS (Next Generation Sequencing)

Table 4. Key Players of Microarray

Table 5. Key Players of FISH (Fluorescent in situ-hybridization)

Table 6. Key Players of Others

Table 7. Global Molecular Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Molecular Oncology Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Molecular Oncology Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Molecular Oncology Market Share by Region (2019-2024)

Table 11. Global Molecular Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Molecular Oncology Market Share by Region (2025-2030)

Table 13. Molecular Oncology Market Trends

Table 14. Molecular Oncology Market Drivers

Table 15. Molecular Oncology Market Challenges

Table 16. Molecular Oncology Market Restraints

Table 17. Global Molecular Oncology Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Molecular Oncology Market Share by Players (2019-2024)

Table 19. Global Top Molecular Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Oncology as of 2023)

Table 20. Global Molecular Oncology Industry Ranking 2022 VS 2023

Table 21. Global 5 Largest Players Market Share by Molecular Oncology Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Molecular Oncology, Headquarters and Area Served

Table 23. Global Key Players of Molecular Oncology, Product and Application

Table 24. Global Key Players of Molecular Oncology, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Molecular Oncology Revenue Market Share by Type (2019-2024)

Table 28. Global Molecular Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Molecular Oncology Revenue Market Share by Type (2025-2030)

Table 30. Global Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Molecular Oncology Revenue Market Share by Application (2019-2024)

Table 32. Global Molecular Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Molecular Oncology Revenue Market Share by Application (2025-2030)

Table 34. North America Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Molecular Oncology Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Molecular Oncology Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Molecular Oncology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Molecular Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Molecular Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Molecular Oncology Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Molecular Oncology Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Molecular Oncology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Molecular Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Molecular Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Molecular Oncology Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Molecular Oncology Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Molecular Oncology Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Molecular Oncology Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Molecular Oncology Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Molecular Oncology Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Molecular Oncology Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Molecular Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Molecular Oncology Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Molecular Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Molecular Oncology Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Molecular Oncology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Molecular Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Molecular Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 66. Roche Diagnostics Company Details

Table 67. Roche Diagnostics Business Overview

Table 68. Roche Diagnostics Molecular Oncology Product

Table 69. Roche Diagnostics Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 70. Roche Diagnostics Recent Development

Table 71. Thermo Fisher Scientific Inc. Company Details

Table 72. Thermo Fisher Scientific Inc. Business Overview

Table 73. Thermo Fisher Scientific Inc. Molecular Oncology Product

Table 74. Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 75. Thermo Fisher Scientific Inc. Recent Development

Table 76. Illumina, Inc. Company Details

Table 77. Illumina, Inc. Business Overview

Table 78. Illumina, Inc. Molecular Oncology Product

Table 79. Illumina, Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 80. Illumina, Inc. Recent Development

Table 81. Qiagen N.V. Company Details

Table 82. Qiagen N.V. Business Overview

Table 83. Qiagen N.V. Molecular Oncology Product

Table 84. Qiagen N.V. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 85. Qiagen N.V. Recent Development

Table 86. Agilent Technologies, Inc. Company Details

Table 87. Agilent Technologies, Inc. Business Overview

Table 88. Agilent Technologies, Inc. Molecular Oncology Product

Table 89. Agilent Technologies, Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 90. Agilent Technologies, Inc. Recent Development

Table 91. Abbott Laboratories Company Details

Table 92. Abbott Laboratories Business Overview

Table 93. Abbott Laboratories Molecular Oncology Product

Table 94. Abbott Laboratories Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 95. Abbott Laboratories Recent Development

Table 96. Bio-Rad Laboratories, Inc. Company Details

Table 97. Bio-Rad Laboratories, Inc. Business Overview

Table 98. Bio-Rad Laboratories, Inc. Molecular Oncology Product

Table 99. Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 100. Bio-Rad Laboratories, Inc. Recent Development

Table 101. Myriad Genetics, Inc. Company Details

Table 102. Myriad Genetics, Inc. Business Overview

Table 103. Myriad Genetics, Inc. Molecular Oncology Product

Table 104. Myriad Genetics, Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 105. Myriad Genetics, Inc. Recent Development

Table 106. Genomic Health, Inc. Company Details

Table 107. Genomic Health, Inc. Business Overview

Table 108. Genomic Health, Inc. Molecular Oncology Product

Table 109. Genomic Health, Inc. Revenue in Molecular Oncology Business (2019-2024) & (US$ Million)

Table 110. Genomic Health, Inc. Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Oncology Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Molecular Oncology Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. NGS (Next Generation Sequencing) Features

Figure 5. Microarray Features

Figure 6. FISH (Fluorescent in situ-hybridization) Features

Figure 7. Others Features

Figure 8. Global Molecular Oncology Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Molecular Oncology Market Share by Application: 2023 VS 2030

Figure 10. Hospitals and Clinics Case Studies

Figure 11. Diagnostic Laboratories Case Studies

Figure 12. Cancer Centers and Specialty Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Molecular Oncology Report Years Considered

Figure 15. Global Molecular Oncology Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Molecular Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Molecular Oncology Market Share by Region: 2023 VS 2030

Figure 18. Global Molecular Oncology Market Share by Players in 2023

Figure 19. Global Top Molecular Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Oncology as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Molecular Oncology Revenue in 2023

Figure 21. North America Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Molecular Oncology Market Share by Type (2019-2030)

Figure 23. North America Molecular Oncology Market Share by Application (2019-2030)

Figure 24. North America Molecular Oncology Market Share by Country (2019-2030)

Figure 25. United States Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Molecular Oncology Market Share by Type (2019-2030)

Figure 29. Europe Molecular Oncology Market Share by Application (2019-2030)

Figure 30. Europe Molecular Oncology Market Share by Country (2019-2030)

Figure 31. Germany Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Molecular Oncology Market Share by Type (2019-2030)

Figure 39. China Molecular Oncology Market Share by Application (2019-2030)

Figure 40. Asia Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Asia Molecular Oncology Market Share by Type (2019-2030)

Figure 42. Asia Molecular Oncology Market Share by Application (2019-2030)

Figure 43. Asia Molecular Oncology Market Share by Region (2019-2030)

Figure 44. Japan Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Molecular Oncology Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Molecular Oncology Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Molecular Oncology Market Share by Country (2019-2030)

Figure 54. Brazil Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Molecular Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Roche Diagnostics Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 62. Illumina, Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 63. Qiagen N.V. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 64. Agilent Technologies, Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 65. Abbott Laboratories Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 66. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 67. Myriad Genetics, Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 68. Genomic Health, Inc. Revenue Growth Rate in Molecular Oncology Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed